| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |